Dermata Therapeutics Stock Forward View - Accumulation Distribution
| DRMA Stock | USD 1.46 0.25 20.66% |
This page provides Accumulation Distribution reference data for Dermata Therapeutics, calculated from historical daily prices. The model output shown here is derived from Dermata Therapeutics's historical price series and is provided for informational purposes.
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume The Accumulation Distribution reference information for Dermata Therapeutics is based on available price data and is intended for informational purposes. Accumulation Distribution Analysis Today
Dermata Therapeutics has current Accumulation Distribution of 0.26. The accumulation distribution (A/D) indicator shows the degree to which Dermata Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Dermata Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Dermata Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.| Volatility | Backtest | Information Ratio |
Dermata Therapeutics Trading Date Momentum
| On March 22 2026 Dermata Therapeutics was traded for 1.46 at the closing time. The top price for the day was 1.84 and the lowest listed price was 1.37 . There was no trading activity during the period. Lack of trading volume on March 22, 2026 did not affect price variability. The overall trading delta against the current closing price is 2.74% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Dermata Therapeutics to competition |
Other Forecasting Options for Dermata Therapeutics
The autocorrelation structure of Dermata Therapeutics' daily returns reveals whether Dermata exhibits momentum, mean-reversion, or random-walk behavior. Separating these elements helps distinguish persistent directional moves from temporary noise in Dermata Stock price data.Dermata Therapeutics Related Equities
The stocks listed below are peers of Dermata Therapeutics within the Health Care space and offer context for ranking and strength. Key comparison metrics include price-to-earnings, profit margin, and revenue growth across Dermata Therapeutics' peer group. How Dermata Therapeutics ranks within this group can shift over time as the competitive picture changes.
| Risk & Return | Correlation |
Dermata Therapeutics Market Strength Events
Market strength indicators applied to Dermata Therapeutics stock help assess momentum and resilience across environments. Investors can use these indicators to make informed decisions about market timing when trading Dermata Therapeutics.
Dermata Therapeutics Risk Indicators
Risk indicator analysis for Dermata Therapeutics is essential for accurately projecting its future price trajectory. The process involves identifying the amount of risk involved in Dermata Therapeutics' investment and either accepting or mitigating it.
| Mean Deviation | 8.02 | |||
| Semi Deviation | 10.1 | |||
| Standard Deviation | 12.57 | |||
| Variance | 158.08 | |||
| Downside Variance | 112.7 | |||
| Semi Variance | 102.08 | |||
| Expected Short fall | -8.62 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Dermata Therapeutics
The amount of media and story coverage tied to Dermata Therapeutics can signal where market attention is concentrating at the moment. A disciplined read of coverage separates durable relevance from temporary noise.
Contributor Headline
Latest Perspective From Macroaxis
Dermata Therapeutics Short Properties
Short-interest signals around Dermata Therapeutics can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
| Common Stock Shares Outstanding | 153 K | |
| Cash And Short Term Investments | 3.2 M |